Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thilo Burkard

Showing results (1-10 of 76) with videos related to

Pageof 8
Sort By:
Praxis|November 28, 2019
[Heart Failure in Africa]Martin Rohacek, Thilo Burkard
Minerva Endocrinology|April 1, 2021
The mTOR-inhibitor everolimus reduces hypervolemia in patients with primary aldosteronismBeckey Trinh, Thilo Burkard
Therapeutische Umschau. Revue Therapeutique|March 24, 2016
[Hyperuricemia, gout and cardiovascular diseases]Karsten Murray, Thilo Burkard
Journal of Clinical Medicine|August 26, 2022
Special Issue: Hypertensive Heart Disease-From Pathophysiology to Therapeutical ChallengesAnnina S Vischer, Thilo Burkard
Advances in Experimental Medicine and Biology|July 16, 2016
Principles of Blood Pressure Measurement - Current Techniques, Office vs Ambulatory Blood Pressure MeasurementAnnina S Vischer, Thilo Burkard
Korean Circulation Journal|March 8, 2022
The Advent of Cuffless Mobile Device Blood Pressure Measurement: Remaining Challenges and PitfallsHae-Young Lee, Thilo Burkard
Diagnostics (Basel, Switzerland)|February 6, 2021
How Should We Measure and Deal with Office Blood Pressure in 2021?Annina S Vischer, Thilo Burkard
Journal of Clinical Medicine|January 23, 2024
Hypertensive Heart Disease: A Narrative Review Series-Part 3: Vasculature, Biomarkers and the Matrix of Hypertensive Heart DiseaseValeriya Nemtsova, Annina S Vischer, Thilo Burkard
Journal of Clinical Medicine|April 13, 2023
Hypertensive Heart Disease: A Narrative Review Series-Part 1: Pathophysiology and Microstructural ChangesValeriya Nemtsova, Annina S Vischer, Thilo Burkard
Journal of Clinical Medicine|September 9, 2023
Hypertensive Heart Disease: A Narrative Review Series-Part 2: Macrostructural and Functional AbnormalitiesValeriya Nemtsova, Thilo Burkard, Annina S Vischer
Pageof 8

Showing results (1-10 of 76) with videos related to

Sort By:
Pageof 8
Praxis|November 28, 2019
[Heart Failure in Africa]Martin Rohacek, Thilo Burkard
Minerva Endocrinology|April 1, 2021
The mTOR-inhibitor everolimus reduces hypervolemia in patients with primary aldosteronismBeckey Trinh, Thilo Burkard
Therapeutische Umschau. Revue Therapeutique|March 24, 2016
[Hyperuricemia, gout and cardiovascular diseases]Karsten Murray, Thilo Burkard
Journal of Clinical Medicine|August 26, 2022
Special Issue: Hypertensive Heart Disease-From Pathophysiology to Therapeutical ChallengesAnnina S Vischer, Thilo Burkard
Advances in Experimental Medicine and Biology|July 16, 2016
Principles of Blood Pressure Measurement - Current Techniques, Office vs Ambulatory Blood Pressure MeasurementAnnina S Vischer, Thilo Burkard
Korean Circulation Journal|March 8, 2022
The Advent of Cuffless Mobile Device Blood Pressure Measurement: Remaining Challenges and PitfallsHae-Young Lee, Thilo Burkard
Diagnostics (Basel, Switzerland)|February 6, 2021
How Should We Measure and Deal with Office Blood Pressure in 2021?Annina S Vischer, Thilo Burkard
Journal of Clinical Medicine|January 23, 2024
Hypertensive Heart Disease: A Narrative Review Series-Part 3: Vasculature, Biomarkers and the Matrix of Hypertensive Heart DiseaseValeriya Nemtsova, Annina S Vischer, Thilo Burkard
Journal of Clinical Medicine|April 13, 2023
Hypertensive Heart Disease: A Narrative Review Series-Part 1: Pathophysiology and Microstructural ChangesValeriya Nemtsova, Annina S Vischer, Thilo Burkard
Journal of Clinical Medicine|September 9, 2023
Hypertensive Heart Disease: A Narrative Review Series-Part 2: Macrostructural and Functional AbnormalitiesValeriya Nemtsova, Thilo Burkard, Annina S Vischer
Pageof 8